Kangtai Bio: Shareholder plans to reduce holdings by 1%

Shenzhen Kangtai Biological Products (SZSE:300601) announced that shareholder Yuan Liping, acting in concert with the controlling shareholder, plans to reduce her holdings by no more than 11,160,000 shares, representing 1% of the company's total share capital. Yuan Liping currently holds 18.06% of the company's shares directly and an additional 4.05% indirectly through related entities. The reduction will occur via block trade or centralized bidding within three months after 15 trading days from the announcement date, and is due to personal financial needs. The company stated that the planned reduction will not affect the company's governance structure, operations, or control.